Document Detail


Intracellular ATP delivery using highly fusogenic liposomes.
MedLine Citation:
PMID:  20072895     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Healthy cells must maintain a high content of adenosine triphosphate (ATP) because almost all energy-requiring processes in cells are driven, either directly or indirectly, by hydrolysis of ATP. During ischemia or hypoxia, reduced blood flow or disturbed oxygen supply results in the disrupted balance of energy production and utilization, and depletion of high-energy phosphates is the fundamental cause of cell damage. Direct intravenous infusion of high-energy phosphates, such as adenosine triphosphate (ATP), has not produced a consistent result because strongly charged molecules like ATP normally cannot pass the cell membrane in sufficient quantities to satisfy tissue metabolic requirements. Furthermore, the half-life of free ATP in blood circulation is very short, limiting its efficacy as a bioenergetic substrate. We have developed a new technique for intracellular delivery of high-energy phosphate into normal or ischemic cells by using specially formulated, highly fusogenic, unilamellar lipid vesicles that contain magnesium-ATP. In vitro studies indicated a rapid fusion with the endothelial cells, protection of endothelial cells, and cardiomyocytes during ischemia. In vivo studies have shown enhanced full-thickness skin wound healing in various animal models. This technique has the potential to reduce or eliminate many detrimental effects caused by ischemia or hypoxia.
Authors:
Sufan Chien
Related Documents :
19855185 - Localisation of eif4a-iii in the nucleolus and splicing speckles is an indicator of pla...
11358965 - H(2)o(2)-induced o(2) production by a non-phagocytic nad(p)h oxidase causes oxidant inj...
20107925 - Oxygen tension modulates neurite outgrowth in pc12 cells through a mechanism involving ...
9241365 - Changes in atp level and iron-induced ultra-weak photon emission in bull spermatozoa, c...
16616945 - Activation of peroxisome proliferator-activated receptor-gamma (ppargamma) induces cell...
19903405 - Survival during cooking and growth from spores of diarrheal and emetic types of bacillu...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural    
Journal Detail:
Title:  Methods in molecular biology (Clifton, N.J.)     Volume:  605     ISSN:  1940-6029     ISO Abbreviation:  Methods Mol. Biol.     Publication Date:  2010  
Date Detail:
Created Date:  2010-01-14     Completed Date:  2010-04-07     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9214969     Medline TA:  Methods Mol Biol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  377-91     Citation Subset:  IM    
Affiliation:
Department of Surgery, University of Louisville, Louisville, KY, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenosine Triphosphate / administration & dosage*,   pharmacokinetics*,   therapeutic use
Animals
Cell Hypoxia / drug effects
Cell Membrane Permeability
Cells, Cultured
Endothelial Cells / cytology,   drug effects
Humans
Ischemia / drug therapy
Liposomes / chemistry,   pharmacokinetics*
Myocytes, Cardiac / cytology,   drug effects
Rabbits
Rats
Rats, Sprague-Dawley
Skin / metabolism
Wound Healing / drug effects*
Grant Support
ID/Acronym/Agency:
AR52984/AR/NIAMS NIH HHS; DK74566/DK/NIDDK NIH HHS; HL64186/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Liposomes; 56-65-5/Adenosine Triphosphate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  ATP-Loaded Liposomes for Targeted Treatment in Models of Myocardial Ischemia.
Next Document:  Lipoplex formation using liposomes prepared by ethanol injection.